Chaperone‐Mediated Autophagy‐Directed Degradation of PI3K in Tumor Cells: Development of Multifunctional Peptide‐Drug Conjugates With Enhanced Penetration and Selectivity
Archiv der Pharmazie · 2026-06 · 359 (6)
DOI: 10.1002/ardp.70289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 03.07.2026. Verfasst von Chenyu Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, Guangzhou Key Laboratory of Tuberculosis Research, Department of Pharmacy, Guangzhou Chest Hospital, Ins…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Chaperone-Mediated Autophagy, Phosphoinositide-3 Kinase Inhibitors, Lung Neoplasms. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Medical Scientific Research Foundation of Guangdong Province of China, Science and Technology Projects in Guangzhou.
Abstract (Originalsprache)
The phosphatidylinositol 3‐kinase (PI3K) pathway is frequently hyperactivated in cancers, promoting tumor growth and resistance to conventional therapies. Conventional PI3K inhibitors often suffer from poor tumor selectivity, systemic toxicity, and the development of acquired resistance. To overcome these issues, we have designed multifunctional peptide‐drug conjugates (PDCs) utilizing chaperone‐mediated autophagy (CMA), a selective lysosomal degradation mechanism, for precise targeting of PI3K. Our approach began with the development of a lead compound, CC‐3, derived from Copanlisib and incorporating a CMA‐recognition motif (KFERQ‐like sequence). We further enhanced this compound by creating TCCC‐1, integrating a tumor‐homing peptide (Thx) and a cell‐penetrating peptide (T2) to improve cellular uptake and specificity. In vitro studies revealed that TCCC‐1 effectively induced PI3K degradation, inhibited downstream pAkt signaling, and promoted apoptosis alongside G2/M cell cycle arrest in non‐small cell lung cancer (NSCLC) cells, including those resistant to Copanlisib. In vivo experiments using NCI‐H460 xenograft models demonstrated that TCCC‐1 achieved up to 97.0% tumor suppression at high doses, surpassing the efficacy of Copanlisib, without causing significant systemic toxicity, organ damage, or metabolic disturbances such as hyperglycemia. These results highlight TCCC‐1 as a promising therapeutic candidate that leverages CMA for precise PI3K degradation, offering enhanced penetration and selectivity against tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Respiratory Disease, Guangzhou Key Laboratory of Tuberculosis Research, Department of Pharmacy, Guangzhou Chest Hospital, Institute of Tuberculosis, Guangzhou Medical University, Guangzhou, China.
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliat…
- Analytical Applications Center, Shimadzu (China) Co. Ltd., Guangzhou Branch, Guangzhou, China.
ORCID-Profile: Xin Deng
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Medical Scientific Research Foundation of Guangdong Province of China
- Science and Technology Projects in Guangzhou
Zitieren
APA
Zhang, C., Zhong, H., Li, X., Xing, Z., Liu, J., Yu, R., & Deng, X. (2026). Chaperone‐Mediated Autophagy‐Directed Degradation of PI3K in Tumor Cells: Development of Multifunctional Peptide‐Drug Conjugates With Enhanced Penetration and Selectivity. Archiv der Pharmazie, 359(6). https://doi.org/10.1002/ardp.70289
Vancouver
Zhang C, Zhong H, Li X, Xing Z, Liu J, Yu R, et al. Chaperone‐Mediated Autophagy‐Directed Degradation of PI3K in Tumor Cells: Development of Multifunctional Peptide‐Drug Conjugates With Enhanced Penetration and Selectivity. Archiv der Pharmazie. 2026;359(6). doi:10.1002/ardp.70289
BibTeX
@article{Zhang2026,
author = {Zhang, Chenyu and Zhong, Honglan and Li, Xiang and Xing, Zhenjian and Liu, Jiaqi and Yu, Rui and Deng, Xin},
title = {Chaperone‐Mediated Autophagy‐Directed Degradation of PI3K in Tumor Cells: Development of Multifunctional Peptide‐Drug Conjugates With Enhanced Penetration and Selectivity},
journal = {Archiv der Pharmazie},
year = {2026},
volume = {359},
number = {6},
doi = {10.1002/ardp.70289}
}
EUVIMED